Deep Learning in Drug Discovery market, Size and Share by 2035
The traditional statistical tools and techniques available for medical data interpretation are known to be associated with challenges related to time and cost.
josephmorale 
This has prompted industry stakeholders to explore the applications of deep learning-based technologies, specifically across drug discovery and diagnosis. In addition, recent investments made in this domain are likely to offer lucrative opportunities to companies offering deep learning-based technologies / solutions within the healthcare industry.
The financial opportunity associated with cell therapy manufacturing market has been analyzed across the following segments:
- Therapeutic Area
- Oncological Disorders
- Infectious Diseases
- Neurological Disorders
- Immunological Disorders
- Endocrine Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Ophthalmic Disorders
- Musculoskeletal Disorders
- Inflammatory Disorders
- Other Disorders
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Rest of the World
The Deep Learning in Drug Discovery and Deep Learning in Diagnostics Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
- Aegicare
- Aiforia Technologies
- Ardigen
- Berg
- Huawei
- Merative
- Nference
- NVIDIA
- Owkin
- Phenomic AI
- Pixel AI
Table of Contents
- PREFACE
- EXECUTIVE SUMMARY
- INTRODUCTION
- MARKET OVERVIEW: DEEP LEARNING IN DRUG DISCOVERY
- MARKET OVERVIEW: DEEP LEARNING IN DIAGNOSTICS
- COMPANY PROFILES
- PORTER’S FIVE FORCES ANALYSIS
- CLINICAL TRIAL ANALYSIS
- FUNDING AND INVESTMENT ANALYSIS
- START-UP HEALTH INDEXING
- COMPANY VALUATION ANALYSIS
- MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DRUG DISCOVERY
- MARKET SIZING AND OPPORTUNITY ANALYSIS: DEEP LEARNING IN DIAGNOSTICS
- DEEP LEARNING IN HEALTHCARE: EXPERT INSIGHTS
- CONCLUDING REMARKS
- INTERVIEW TRANSCRIPTS
- APPENDIX 1: TABULATED DATA
- APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/view_document/deep-learning-in-drug-discovery-market/156.html
You may also be interested in the following titles:
You may also like to learn what our experts are sharing in Roots educational series:
|
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
